Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Jeffrey J. Stoddard"'
Autor:
Brandon J. Patterson, PharmD, PhD, Philip O. Buck, PhD, MPH, Desmond Curran, PhD, Desirée Van Oorschot, MSc, Justin Carrico, BS, William L. Herring, PhD, Yuanhui Zhang, PhD, Jeffrey J. Stoddard, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 596-604 (2021)
Objective: To investigate the potential public health impact of adult herpes zoster (HZ) vaccination with the adjuvanted recombinant zoster vaccine (RZV) in the United States in the first 15 years after launch. Methods: We used a publicly available m
Externí odkaz:
https://doaj.org/article/db6d36ff1baa4e9fac9d525a5a16522a
Autor:
Giuseppe Del Giudice, Jörg J. Goronzy, Beatrix Grubeck-Loebenstein, Paul-Henri Lambert, Tomas Mrkvan, Jeffrey J. Stoddard, T. Mark Doherty
Publikováno v:
npj Aging and Mechanisms of Disease, Vol 4, Iss 1, Pp 1-8 (2017)
Abstract The progressive increase of the aged population worldwide mandates new strategies to ensure sustained health and well-being with age. The development of better and/or new vaccines against pathogens that affect older adults is one pivotal int
Externí odkaz:
https://doaj.org/article/a8ee1fc6f7b64f2390b32b767db0e7f4
Autor:
Louis Fries, Vivek Shinde, Jeffrey J. Stoddard, D. Nigel Thomas, Eloi Kpamegan, Hanxin Lu, Gale Smith, Somia P. Hickman, Pedro Piedra, Gregory M. Glenn
Publikováno v:
Immunity & Ageing, Vol 14, Iss 1, Pp 1-14 (2017)
Abstract Background A preventative strategy for Respiratory Syncytial Virus (RSV) infection constitutes an under-recognized unmet medical need among older adults. Four formulations of a novel recombinant RSV F nanoparticle vaccine (60 or 90 μg RSV F
Externí odkaz:
https://doaj.org/article/ede5a421c05f45379e58ee05f42f78c7
Autor:
Jeffrey J. Stoddard, Philip O. Buck, Desmond Curran, William L. Herring, Desiree Van Oorschot, Yuanhui Zhang, Justin Carrico, Brandon J. Patterson
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 596-604 (2021)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective To investigate the potential public health impact of adult herpes zoster (HZ) vaccination with the adjuvanted recombinant zoster vaccine (RZV) in the United States in the first 15 years after launch. Methods We used a publicly available mod
Autor:
Katherine Hicks, Justin Carrico, Saurabh P Nagar, Jeffrey J. Stoddard, Jean-Etienne Poirrier, Jessica K DeMartino, Juliana Meyers
Publikováno v:
Open Forum Infectious Diseases
Background Herpes zoster (HZ), or shingles, is a common neurocutaneous disease caused by the reactivation of latent varicella zoster virus that often includes rash and neuropathic pain that may last for months. Opioids and other analgesics may be pre
Publikováno v:
Journal of Clinical Psychopharmacology. 35:442-446
Pharmacological treatment is central to effective management of schizophrenia. Prescribing clinicians have an increasing array of options from which to choose, and oral antipsychotic polypharmacy is common in routine clinical practice. Practice guide
Autor:
Jörg J. Goronzy, Paul-Henri Lambert, Jeffrey J. Stoddard, Giuseppe Del Giudice, T. Mark Doherty, Tomas Mrkvan, Beatrix Grubeck-Loebenstein
Publikováno v:
NPJ Aging and Mechanisms of Disease
npj Aging and Mechanisms of Disease, Vol 4, Iss 1, Pp 1-8 (2017)
npj Aging and Mechanisms of Disease, Vol 4, Iss 1, Pp 1-8 (2017)
The progressive increase of the aged population worldwide mandates new strategies to ensure sustained health and well-being with age. The development of better and/or new vaccines against pathogens that affect older adults is one pivotal intervention
Autor:
Vivek Shinde, Eric Hillson, Ann Colosia, Jeffrey J. Stoddard, Josephine Mauskopf, Catherine Copley-Merriman, Jin Yang
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 8, p e0182321 (2017)
PLoS ONE, Vol 12, Iss 8, p e0182321 (2017)
Objective This review was undertaken to assess the historical evidence of the disease incidence and burden of laboratory-confirmed respiratory syncytial virus (RSV) in medically attended older adults. Design A qualitative systematic literature review
Publikováno v:
Immunotherapy. 6:395-408
Developing effective vaccines against Neisseria meningitidis serogroup B has been challenging for several reasons, including the fact that the capsular polysaccharide of N. meningitidis serogroup B is a poor antigen. Therefore, studies have focused o
Autor:
Angelika Banzhoff, Jeffrey J. Stoddard
Publikováno v:
Human Vaccines & Immunotherapeutics. 8:398-402
Seasonal influenza causes clinical illness and hospitalization in all age groups; however, conventional inactivated vaccines have only limited efficacy in young children. MF59(®), an oil-in-water emulsion adjuvant, has been used since the 1990s to e